1. The results of therapy with venetoclax, daratumumab and plerixafor as part of the conditioning regimen in chemotherapy-refractory acute leukemia in children
   M. A. Klimentova et al, 2023, Pediatric Hematology/Oncology and Immunopathology CrossRef
2. A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation
   Max Bittrich et al, 2023, Transfusion Medicine and Hemotherapy CrossRef
3. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients
   Te-Lin Hsu et al, 2023, Transfusion Medicine and Hemotherapy CrossRef
4. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome
   Johanna Detzner et al, 2020, Toxins CrossRef
5. Plerixafor and granulocyte colony stimulating factor for poor mobilizers in patients undergoing autologous peripheral hematopoietic stem cell transplantation: Single institution study
   Jean El Cheikh et al, 2023, Frontiers in Transplantation CrossRef